X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 12/Aug 22:20

Anterix (ATEX) Reports Q1 Loss, Misses Revenue Estimates

Anterix (ATEX) delivered earnings and revenue surprises of +11.11% and -6.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Anterix (ATEX) Reports Q1 Loss, Misses Revenue Estimates

zacks.com - 12/Aug 22:20

Anterix (ATEX) delivered earnings and revenue surprises of +11.11% and -6.71%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Hyliion Holdings Corp. (HYLN) Reports Q2 Loss, Misses Revenue Estimates

zacks.com - 12/Aug 21:45

Hyliion (HYLN) delivered earnings and revenue surprises of +11.11% and -2.26%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Hyliion Holdings Corp. (HYLN) Reports Q2 Loss, Misses Revenue Estimates

zacks.com - 12/Aug 21:45

Hyliion (HYLN) delivered earnings and revenue surprises of +11.11% and -2.26%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Lionsgate Studios Corp. (LION) Reports Q1 Loss, Misses Revenue Estimates

zacks.com - 07/Aug 21:40

Lionsgate Studios Corp. (LION) delivered earnings and revenue surprises of -166.67% and -6.71%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Lionsgate Studios Corp. (LION) Reports Q1 Loss, Misses Revenue Estimates

zacks.com - 07/Aug 21:40

Lionsgate Studios Corp. (LION) delivered earnings and revenue surprises of -166.67% and -6.71%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates

zacks.com - 07/Aug 23:20

VistaGen Therapeutics (VTGN) delivered earnings and revenue surprises of 0.00% and -62.46%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 08/Aug 21:15

Femasys (FEMY) delivered earnings and revenue surprises of +11.11% and -48.88%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 06/Aug 22:50

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -11.11% and -84.12%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 06/Aug 22:50

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -11.11% and -84.12%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Intrusion Inc. (INTZ) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 22:05

Intrusion (INTZ) delivered earnings and revenue surprises of -11.11% and +4.06%, respectively, for the quarter ended June 2025. Do the numbers hold...

Les derniers communiqués